Brief: Insulet Announces U.S. Rollout Of Enhanced Omnipod® 5 Algorithm And Expands Compatibility With Abbott’S Freestyle Libre 3 Plus Sensor
03/06/2026 12:26
BRIEF-Insulet Announces U.S. Rollout Of Enhanced Omnipod® 5 Algorithm And Expands Compatibility With Abbott’S Freestyle Libre 3 Plus Sensor June 3 (Reuters) - Insulet Corp PODD.O:
INSULET ANNOUNCES U.S. ROLLOUT OF ENHANCED OMNIPOD® 5 ALGORITHM AND EXPANDS COMPATIBILITY WITH ABBOTT’S FREESTYLE LIBRE 3 PLUS SENSOR
Source text: ID:nBw8tLBwCa
Further company coverage: PODD.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Abbott Laboratories
See all newsPress Digest: Wall Street Journal - June 29
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports (updated)
US DOJ closes criminal probe into Abbott over baby formula plant, WSJ reports
Factbox: Major deals involving US drugmakers and biotechs over the past decade
ALZpath signs licensing deal with Abbott to develop Alzheimer's blood test